Chemogenomics is a new strategy in drug discovery for interrogating all molecules capable of interacting with all biological targets. Because of the almost infinite number of drug-like organic molecules, bench-based experimental chemogenomics methods are not generally feasible. Several in silico chemogenomics models have therefore been developed for high-throughput screening of large numbers of drug candidate compounds and target proteins. In previous studies, we described two novel bi-modal PLS approaches. These methods provide a significant advantage in that they enable direct connections to be made between biological activities and ligand and protein descriptors. In this special issue, we review these two PLS-based approaches using two different chemogenomics datasets for illustration. We then compare the predictive and interpretive performance of the two methods using the same congeneric data set.